Filing Flows › Cabot (CBT) › Who owns the stock
Who owns Cabot (CBT) stock
370 funds reported Cabot (CBT) shares in their latest 13F filings, worth $5.1B in all. The largest holder is BlackRock ($633M). Last quarter 180 funds added to their stakes and 137 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 6,973,153 | $633M | increase | 2026-06-30 |
| Vanguard Group | 5,928,895 | $393M | decrease | 2025-12-31 |
| Earnest Partners LLC | 3,345,689 | $304M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 3,076,935 | $279M | decrease | 2026-06-30 |
| American Century Companies | 2,768,176 | $251M | increase | 2026-06-30 |
| Wellington Management Group LLP | 2,416,471 | $219M | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 2,321,142 | $211M | decrease | 2026-06-30 |
| State Street | 2,165,434 | $197M | increase | 2026-06-30 |
| Fuller & Thaler Asset Management | 2,003,514 | $182M | decrease | 2026-06-30 |
| Dimensional Fund Advisors LP | 1,926,205 | $175M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 1,778,678 | $162M | increase | 2026-06-30 |
| Bank of America | 1,660,122 | $151M | increase | 2026-06-30 |
| FMR LLC | 1,560,741 | $142M | increase | 2026-06-30 |
| T. Rowe Price Investment Management | 1,403,988 | $128M | increase | 2026-06-30 |
| SEI Investments | 1,203,052 | $109M | increase | 2026-06-30 |
Cabot's latest quarter
Cabot, Q4 FY26: revenue $1.0B (+12% year over year), operating margin 12.0%, net earnings $66.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CBT stock?
By the latest 13F filings: BlackRock ($633M); Vanguard Group ($393M); Earnest Partners LLC ($304M); Vanguard Portfolio Management LLC ($279M); American Century Companies ($251M).
What is the short interest in CBT?
4,923,877 shares were sold short at the 2026-10-15 settlement, 11.38% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.